JPS6243669B2 - - Google Patents
Info
- Publication number
- JPS6243669B2 JPS6243669B2 JP55026117A JP2611780A JPS6243669B2 JP S6243669 B2 JPS6243669 B2 JP S6243669B2 JP 55026117 A JP55026117 A JP 55026117A JP 2611780 A JP2611780 A JP 2611780A JP S6243669 B2 JPS6243669 B2 JP S6243669B2
- Authority
- JP
- Japan
- Prior art keywords
- uricase
- buffer
- medium
- activity
- borax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010092464 Urate Oxidase Proteins 0.000 claims description 49
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 17
- 238000012258 culturing Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000000872 buffer Substances 0.000 description 38
- 239000002609 medium Substances 0.000 description 35
- 230000000694 effects Effects 0.000 description 30
- 229910021538 borax Inorganic materials 0.000 description 23
- 239000004328 sodium tetraborate Substances 0.000 description 23
- 235000010339 sodium tetraborate Nutrition 0.000 description 23
- 108090000790 Enzymes Proteins 0.000 description 22
- 102000004190 Enzymes Human genes 0.000 description 22
- 229940088598 enzyme Drugs 0.000 description 22
- 239000000243 solution Substances 0.000 description 18
- 239000006228 supernatant Substances 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 15
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 14
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 13
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 13
- 235000011130 ammonium sulphate Nutrition 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 12
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 229940116269 uric acid Drugs 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000000502 dialysis Methods 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000004202 carbamide Substances 0.000 description 7
- -1 meletitose Chemical compound 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- 229920000298 Cellophane Polymers 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000013028 medium composition Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000228108 Groenewaldozyma salmanticensis Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N L-sorbitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004251 Ammonium lactate Substances 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- SRBFZHDQGSBBOR-MBMOQRBOSA-N alpha-D-arabinopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-MBMOQRBOSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940059265 ammonium lactate Drugs 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- SRBFZHDQGSBBOR-KLVWXMOXSA-N beta-L-arabinopyranose Chemical compound O[C@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-KLVWXMOXSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 229910000361 cobalt sulfate Inorganic materials 0.000 description 1
- 229940044175 cobalt sulfate Drugs 0.000 description 1
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002897 organic nitrogen compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 238000006400 oxidative hydrolysis reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
本発明は発酵法によるウリカーゼの製造法に関
する。さらに詳しくは本発明はトルロプシス属に
属し、ウリカーゼ生産能を有する微生物を栄養培
地に培養し、培養物中にウリカーゼを生成せし
め、これを採取することを特徴とするウリカーゼ
の製造法に関する。
ウリカーゼ(EC1.7.3.3)は尿酸を酸化的に加
水分解して、アラントインと過酸化水素および炭
酸ガスを生成する作用を触媒する酵素である。ウ
リカーゼは血中あるいは尿中の尿酸の測定に使用
される。
従来、発酵法によるウリカーゼの製造法として
は、ミクロコツカス属、ブレビバクテリウム属
(特公昭44−14783号公報)、キヤンデイダ属(特
公昭42−5192号公報)、ストレプトミセス属
(Agric.Bial.Chem.Vol.33、1282、1969)、エンテ
ロバクター属(特開昭54−11296号公報)、トリコ
スポロン属(特開昭54−119086号公報)などに属
する微生物を用いる多くの方法が知られている。
本発明者らはウリカーゼを生産する能力を有す
る微生物を広範囲にわたり検索した結果、天然界
(鳥類の糞)から分離したトルロプシス属に属す
る酵母(TN−1023株と称する)がウリカーゼを
著量に生産することを見出し本発明を完成するに
至つた。
本菌の菌学的性質は次の通りである。
1 各培地における生育状態
(1) YM液体培地※1
25℃、3日の静置培養を行なつた後の菌体
の生育は良好で粉末状に沈降しており、皮膜
の形成はない。細胞の形態は卵形を示し、大
きさは(2−4)×(2.5−5)ミクロン、増
殖は多極出芽による。
(2) YM寒天培地※2
25℃で生育は良好で、コロニーの表面は平
滑、灰白色バター質である。コロニ周縁は全
縁であり、台状に降起している。
(3) YMゼラチン培地※3での巨大コロニーの
生成25℃、50日の培養で直径33mmのやや不規
則な円形の巨大コロニーを生成する。コロニ
ー周縁は波状であり、台状に降起し、バター
質で褐色を帯びたクリーム色を呈した。
(4) 馬鈴薯抽出寒天培地によるスライド培養細
胞は全て卵形、栄養細胞のみで、偽菌糸、菌
糸、胞子、分裂子等は認められない。
※1 YM液体培地組成:
ペプトン5g、酵母エキス3g、麦芽エキ
ス3gおよびブドウ糖10gを水で溶解後、
全体を水で1000mlとする。
※2 YM寒天培地組成:
ペプトン5g、酵母エキス3g、麦芽エキ
ス3g、ブドウ糖10gおよび寒天20gを水
で溶解後全体を水で1000mlとする。
※3 YMゼラチン培地組成:
ペプトン5g、酵母エキス3g、麦芽エキ
ス3g、ブドウ糖10gおよびゼラチン200
gを水で溶解後、全体を水で1000mlとす
る。
2 子のう胞子の形成
石膏・醋酸ソーダ培地、ゴドロコワ培地、改
良ゴドロコワ培地、グルコース・ペプトン培
地、フオウエル培地、クレイン培地、ニンジン
片培地、麦芽汁寒天培地、野菜汁寒天培地など
の培地を用いて、子のう胞子の形成の有無を検
討したが、全く認められなかつた。
3 射出胞子の形成
YM寒天培地、麦芽汁寒天培地を用いて射出
胞子形成の有無を検討したが、全く認められな
かつた。
4 生理的性質
(1) 最適生育条件:PH5−6、温度23−33℃
(2) 生育の範囲:PH2−7.5、温度11−39℃
(3) 硝酸塩の同化:なし
(4) 脂肪の分解:なし
(5) 尿素の分解:なし
(6) ゼラチンの液化:なし
(7) 耐浸透圧:NaClの生育限界濃度21%
(8) カロチノイドの生成:なし
(9) 顕著な有機酸の生成:なし
(10) デンプン様物質の生成:なし
(11) ビタミンの要求性:ビオチンを生育に要求
する。
(12) グルコシドの分解性:あり(アルブテンを
分解する)
(13) エステルの生成:なし
5 糖の発酵性
D−グルコース、D−ガラクトース、シヨ
糖、トレハロースを発酵する。ラフイノースの
1/3分子を発酵する。
麦芽糖、乳糖、メリビオース、メレチトー
ス、D−(+)−セロビオース、α−メチルグル
コシドなどを発酵しない。
6 資化性
資化するもの:D−グルコース、D−ガラク
トース、シヨ糖、麦芽糖、ラフイノース、グリ
セロール、エタノール、トレハロース、D−
(+)−セロビオース、L−(−)ソルボース、
L−(+)アラビノース、D−キシロース、D
−(+)−マンノース、D−(−)−フラクトー
ス、D−(+)−メレチトース、α−メチルグル
コシド、マンニトール、D−(−)−ソルビトー
ル、ズルシトール、α−ケトグルタル酸ナトリ
ウム、クエン酸ナトリウム、コハク酸ナトリウ
ム、リンゴ酸ナトリウム、DL−乳酸アンモニ
ウム(微弱)。
資化しないもの:乳糖、メリビオース、イノ
シトール、D−(−)−アラビノース、L−ラム
ノース、可溶性デンプン、イヌリン、デキスト
リン、セルロース、リポース、meso−エリス
リトール、酢酸ナトリウム、ギ酸ナトリウム。
本菌株の以上の諸性質をロダーの「ザ・イース
ト(1970)」に記載の既知菌種のそれと比較した
ところ、トルロプシス・キヤンデイダ
(Torulopsis candida)、トルロプシス・ダツチラ
(Torulopsis dattila)、トルロプシス・サルマン
チセンシス(Torulopsis salmanticensis)など
に多くの類似点が見出された。しかし、生理的性
質を比較すると、トルロプシス・キヤンデイダと
TN1023の間には、グルコース、ガラクトース、
シヨ糖、ラフイノースの発酵性、乳糖、L−アラ
ビノース、L−ラムノース、可溶性デンプン、ビ
タミン要求性などの点に相違がみとめられる。ま
た、トルロプシス・ダツチラとTN1023の間には
ガラクトースおよびラフイノースの発酵性、D−
アラビノース、セロビオース、D−キシロース、
DL−乳酸、コハク酸、クエン酸、ビタミン要求
性、耐浸透圧性などに相違があり、トルロプシ
ス・サルマンチセンシスとTN1023との間の性質
の相違点はマルトースおよびラフイノースの発酵
性、ラクトース、メリビオース、可溶性デンプ
ン、グリセロールの資化性、ビタミン要求性、耐
浸透圧性などにみとめられた。従つて、本菌株
(TN1023株)をトルロプシス属の新種と判定し、
トルロプシス・ウリコキシダンス(Torulopsis
uricoxidans)TN1023と命名した。
本菌株は工業技術院微生物工業技術研究所にト
ルロプシス・ウリコキシダンスTN1023という名
称で微工研菌寄第5391号として寄託されている。
本発明に使用される微生物は、トルロプシス属
に属し、ウリカーゼを生産する能力を有するもの
であれば、いずれの菌株でもよい。好適な菌株の
例はトルロプシス・ウリコキシダンスTN1023
(微工研菌寄第5391号)である。
本発明に使用される培地は、炭素源、窒素源、
無機物、その他使用菌株の必要とする微量栄養素
を程よく含有するものであれば合成培地、天然培
地のいずれも使用可能である。
炭素源としては、グルコース、フラクトース、
シユクロース、糖蜜などの糖類、エタノール、グ
リセロール、ソルビトール、マンニトールなどの
アルコール類、α−ケトグルタル酸、クエン酸、
リンゴ酸、コハク酸などの有機酸などのほか尿酸
なども用いられる。
窒素源としては塩化アンモニウム、硫酸アンモ
ニウム、リン酸アンモニウム、尿素などのほか、
L−グルタミン酸などのアミノ酸類、あるいは尿
酸などの無機あるいは有機の窒素化合物が使用で
きる。さらに窒素源としては、ペプトン、肉エキ
ス、酵母エキス、コーン・スチープ・リカーなど
窒素含有天然物も使用できる。無機物としては、
例えば塩化ナトリウム、塩化カリウム、リン酸カ
リウム、リン酸ナトリウム、硫酸マグネシウム、
硫酸アンモニウム、硫酸鉄、硫酸コバルト、硫酸
マンガン、塩化コバルトなどが単独または組合わ
せて用いられる。そほかビオチン、チアミンなど
のビタミン類、さらに必要に応じて、アデニン、
ウラシル、オロツト酸などの核酸関連物質が単独
または組合わせて用いられる。
培養は、通常振盪培養あるいは通気撹拌培養で
行なう。培養温度は15〜38℃、好適には23〜33℃
で行なう。培地のPHは2.0〜7.5、好適には4.0〜
9.0の範囲で行なう。1−4日間培養することに
より、培養物中、主として菌体中にウリカーゼが
生成蓄積する。
培養物中からのウリカーゼの採取は次のように
行なう。
培養終了後、培養物中から菌体を遠心分離など
により取得し、ついでこの菌体を適当な手段で破
砕し、破砕液から遠心分離等によつて上清液を得
る。上清液を通常酵素精製に用いられる方法、た
とえば塩析、有機溶媒沈殿、透析、イオン交換セ
ルロースクロマト、セフアデツクスクロマト、ア
フイニテイクロマト、限外過、凍結乾燥などの
方法にて処理する。かくして精製ウリカーゼを得
ることができる。
また、ウリカーゼ活性の測定は、尿酸の示す
283nmにおける吸収(分子吸光係数、1.238×
104)の酸素反応による減少度を測定することによ
つて活性を算出する方法によつた。(特開昭54−
119086号公報参照)酵素活性は、1分間(37℃、
PH8.5)に1μmoleの尿酸を分解する酵素量を1
単位(U)とする。
次に実施例2で得られた酵素標品によるウリカ
ーゼの性質を示す。
(1) 至適PH
酵素標品を種々のPH(5.8、6.0、6.5、7.0、
7.5、8.0、8.5、9.0、9.2)のM/20ホウ砂・
M/10KH2PO4バツフアーに0.02U/mlになる
ように溶解する。これらの酵素液0.5mlを使用
して前記の方法にしたがつて酵素活性を測定し
た。反応液中のバツフアーは第1表に示したPH
8.5のバツフアーに代えて上記の酵素の溶解に
用いた種々のPHのバツフアーを使用した。PH
8.5での活性を100とした場合の各PHにおおける
活性の関係は第1図に示すようになり、PH8.5
付近に至適PHが認められた。
(2) 安定のPH範囲
この試験で安定PHを調べるためのバツフアー
はPH範囲によつて次の2種類のバツフアーを用
いた。すなわち、PH6.0〜9.8の範囲ではM/20
ホウ砂・M/10KH2PO4のバツフアーをPH5.0〜
6.0の範囲ではM/40ホウ砂・M/40コハク酸
のバツフアーを使用し、各PHのバツフアーによ
つてウリカーゼ活性0.2U/mlになるように酵
素標品を溶解し、25℃で20時間保つたのち、こ
れらの酵素溶液1mlにM/20ホウ砂・M/
10KH2PO4バツフアー(PH8.5)9mlを加えてPH
を8.5付近とした。これらの酵素サンプル0.5ml
を用い前記の方法によつて酵素活性を測定し、
相対活性で示した結果を第2図に示す。本酵素
はPH7.0からPH9.8の範囲まで安定であつた。
(3) 至適温度
酵素標品を0.02U/mlになるようにM/20ホ
ウ砂・M/10KH2PO4(PH8.5)に溶解する。反
応温度を20、25、30、35、37、40、45、50、
55、60、65、70℃とする。前記ウリカーゼ活性
の測定法で反応温度のみを変更して至適反応温
度をしらべた。結果は第3図に示すようにな
り、至適温度は37℃から40℃の範囲にあること
が判つた。
(4) 安定温度範囲
酵素標品を0.02U/mlになるようにM/20ホ
ウ砂・M/10KH2PO4バツフアー(PH8.5)に溶
解し、第4図に示す各温度に10分間保持したの
ち、各0.5mlを用いて前記の方法にしたがつて
酵素活性を測定した。もつとも活性の高い値を
100とした場合の各温度における相対活性を第
4図に示す。本酵素は55℃までの温度では30分
の処理によつても失活は認められず、65℃、10
分の処理によつても約40%の活性が残存してい
た。
(5) 基質特異性
酵素標品を0.02U/mlになるようにM/20ホ
ウ砂・M/10KH2PO4バツフアー(PH8.5)に溶
解する。基質として第1表に示すものを用いる
以外は前記ウリカーゼ活性の測定法と同様にし
て、基質の減少量を測定する。吸光度の測定波
長は、各基質における最大吸収波長を用いる。
尿酸を基質とする場合の活性を100とした場合
の各基質での相対活性を第1表に示す。
The present invention relates to a method for producing uricase by fermentation. More specifically, the present invention relates to a method for producing uricase, which comprises culturing a microorganism belonging to the genus Torulopsis and capable of producing uricase in a nutrient medium, producing uricase in the culture, and collecting the microorganism. Uricase (EC1.7.3.3) is an enzyme that catalyzes the oxidative hydrolysis of uric acid to produce allantoin, hydrogen peroxide, and carbon dioxide. Uricase is used to measure uric acid in blood or urine. Conventionally, methods for producing uricase using fermentation methods include Micrococcus spp., Brevibacterium spp. Many methods are known that use microorganisms belonging to the genus Enterobacter (Japanese Unexamined Patent Publication No. 11296/1986), the genus Trichosporon (Japanese Unexamined Patent Publication No. 119086/1983), etc. . As a result of an extensive search for microorganisms capable of producing uricase, the present inventors found that a yeast belonging to the genus Torulopsis (referred to as strain TN-1023) isolated from the natural world (bird droppings) produced uricase in significant amounts. The present invention was completed based on this discovery. The mycological properties of this bacterium are as follows. 1 Growth status in each medium (1) YM liquid medium *1 After static culture at 25°C for 3 days, the growth of the bacterial cells was good, and the cells settled in a powder form, with no film formation. The cell morphology is oval, the size is (2-4) x (2.5-5) microns, and proliferation is due to multipolar budding. (2) YM agar medium *2 Growth is good at 25℃, and the surface of the colonies is smooth and buttery gray. The periphery of the colony is entire and rises in a platform-like manner. (3) Generation of giant colonies in YM gelatin medium *3 After culturing at 25℃ for 50 days, giant colonies with a diameter of 33 mm are generated. The periphery of the colony was wavy and descended into a platform, and was buttery and brownish cream in color. (4) All cells cultured on slides using potato extract agar medium are oval in shape and contain only vegetative cells, with no pseudohyphae, hyphae, spores, fission, etc. observed. *1 YM liquid medium composition: After dissolving 5g of peptone, 3g of yeast extract, 3g of malt extract and 10g of glucose in water,
Make the total volume to 1000ml with water. *2 YM agar medium composition: Dissolve 5 g of peptone, 3 g of yeast extract, 3 g of malt extract, 10 g of glucose, and 20 g of agar in water, then make up to 1000 ml with water. *3 YM gelatin medium composition: peptone 5g, yeast extract 3g, malt extract 3g, glucose 10g and gelatin 200%
Dissolve g in water and make up to 1000ml with water. 2. Formation of ascospores Using a medium such as gypsum/sodium acetate medium, Godlokova medium, improved Godlokova medium, glucose/peptone medium, Fewell medium, Crane medium, carrot piece medium, wort agar medium, vegetable juice agar medium, etc. The presence or absence of ascospore formation was examined, but no ascospores were observed. 3 Formation of extruded spores The presence or absence of extruded spore formation was examined using YM agar medium and wort agar medium, but no extruded spore formation was observed. 4 Physiological properties (1) Optimal growth conditions: PH5-6, temperature 23-33℃ (2) Growth range: PH2-7.5, temperature 11-39℃ (3) Nitrate assimilation: None (4) Fat decomposition : None (5) Urea decomposition: None (6) Gelatin liquefaction: None (7) Osmotic pressure resistance: NaCl growth limit concentration 21% (8) Carotenoid production: None (9) Significant organic acid production: None (10) Production of starch-like substances: None (11) Requirement for vitamins: Requires biotin for growth. (12) Degradability of glucosides: Yes (decomposes albutene) (13) Formation of esters: None 5 Fermentability of sugars Ferment D-glucose, D-galactose, sucrose, and trehalose. Roughinose's
Ferment 1/3 molecule. It does not ferment maltose, lactose, melibiose, meletitose, D-(+)-cellobiose, α-methylglucoside, etc. 6 Assimilation Assimilation: D-glucose, D-galactose, sucrose, maltose, raffinose, glycerol, ethanol, trehalose, D-
(+)-cellobiose, L-(-) sorbose,
L-(+)arabinose, D-xylose, D
-(+)-mannose, D-(-)-fructose, D-(+)-meletitose, α-methylglucoside, mannitol, D-(-)-sorbitol, dulcitol, sodium α-ketoglutarate, sodium citrate, Sodium succinate, sodium malate, DL-ammonium lactate (minor). Things that cannot be assimilated: lactose, melibiose, inositol, D-(-)-arabinose, L-rhamnose, soluble starch, inulin, dextrin, cellulose, lipose, meso-erythritol, sodium acetate, sodium formate. When the above-mentioned properties of this strain were compared with those of the known bacterial species described in Roder's "The East (1970)", it was found that Torulopsis candida, Torulopsis dattila, and Torulopsis salmanchi. Many similarities were found with Torulopsis salmanticensis and others. However, when comparing physiological properties, Torulopsis candida and
Between TN1023, glucose, galactose,
Differences can be seen in the fermentability of sucrose and raffinose, lactose, L-arabinose, L-rhamnose, soluble starch, and vitamin requirement. Furthermore, between Torulopsis datuchira and TN1023, there is a difference in the fermentability of galactose and raffinose, D-
arabinose, cellobiose, D-xylose,
There are differences in DL-lactic acid, succinic acid, citric acid, vitamin requirements, osmotic pressure resistance, etc., and the differences in properties between Torulopsis salmanticensis and TN1023 are the fermentability of maltose and raffinose, lactose, melibiose, It was recognized for its ability to assimilate soluble starch and glycerol, require vitamins, and resist osmotic pressure. Therefore, we determined that this bacterial strain (TN1023 strain) is a new species of the genus Torulopsis.
Torulopsis uricoxidans (Torulopsis)
uricoxidans) TN1023. This strain has been deposited with the National Institute of Microbiology, Agency of Industrial Science and Technology under the name Torulopsis uricoxidans TN1023, and as Fiber Science and Technology Research Institute No. 5391. The microorganism used in the present invention may be any strain as long as it belongs to the genus Torulopsis and has the ability to produce uricase. An example of a suitable strain is Torulopsis uricoxidans TN1023.
(Feikoken Bibori No. 5391). The culture medium used in the present invention includes a carbon source, a nitrogen source,
Both synthetic and natural media can be used as long as they contain appropriate amounts of inorganic substances and other micronutrients required by the strain used. Carbon sources include glucose, fructose,
Sugars such as sucrose and molasses, alcohols such as ethanol, glycerol, sorbitol, and mannitol, α-ketoglutaric acid, citric acid,
In addition to organic acids such as malic acid and succinic acid, uric acid is also used. Nitrogen sources include ammonium chloride, ammonium sulfate, ammonium phosphate, urea, etc.
Amino acids such as L-glutamic acid, or inorganic or organic nitrogen compounds such as uric acid can be used. Furthermore, nitrogen-containing natural products such as peptone, meat extract, yeast extract, and corn steep liquor can also be used as nitrogen sources. As an inorganic substance,
For example, sodium chloride, potassium chloride, potassium phosphate, sodium phosphate, magnesium sulfate,
Ammonium sulfate, iron sulfate, cobalt sulfate, manganese sulfate, cobalt chloride, and the like are used alone or in combination. Other vitamins such as biotin and thiamin, and if necessary, adenine,
Nucleic acid-related substances such as uracil and orotic acid are used alone or in combination. Culture is usually carried out by shaking culture or aerated agitation culture. Culture temperature is 15-38℃, preferably 23-33℃
Let's do it. The pH of the medium is 2.0-7.5, preferably 4.0-
Perform within the range of 9.0. By culturing for 1 to 4 days, uricase is produced and accumulated in the culture, mainly in the bacterial cells. Uricase is collected from the culture as follows. After completion of the culture, the bacterial cells are obtained from the culture by centrifugation or the like, and then the bacterial cells are disrupted by an appropriate means, and a supernatant liquid is obtained from the crushed liquid by centrifugation or the like. The supernatant solution is treated by methods commonly used for enzyme purification, such as salting out, organic solvent precipitation, dialysis, ion exchange cellulose chromatography, sepadex chromatography, affinity chromatography, ultrafiltration, and freeze drying. . Purified uricase can thus be obtained. In addition, the measurement of uricase activity is an indicator of uric acid.
Absorption at 283 nm (molecular extinction coefficient, 1.238×
The activity was calculated by measuring the degree of decrease in 10 4 ) due to oxygen reaction. (Unexamined Japanese Patent Publication 1973-
(Refer to Publication No. 119086) Enzyme activity was measured for 1 minute (37℃,
PH8.5) and the amount of enzyme that breaks down 1 μmole of uric acid.
The unit is (U). Next, the properties of uricase using the enzyme preparation obtained in Example 2 will be shown. (1) Optimal PH Enzyme preparations were adjusted to various pH levels (5.8, 6.0, 6.5, 7.0,
7.5, 8.0, 8.5, 9.0, 9.2) M/20 borax.
Dissolve in M/10KH 2 PO 4 buffer to a concentration of 0.02U/ml. Enzyme activity was measured using 0.5 ml of these enzyme solutions according to the method described above. The buffer in the reaction solution has a pH shown in Table 1.
In place of the 8.5 buffer, various pH buffers used to dissolve the enzymes described above were used. PH
When the activity at 8.5 is set as 100, the relationship between the activities at each PH is shown in Figure 1.
Optimal pH was found nearby. (2) Stable PH range In this test, the following two types of buffers were used to check the stable PH depending on the PH range. In other words, in the range of PH6.0 to 9.8, M/20
Borax M/10KH 2 PO 4 buffer from PH5.0
In the range of 6.0, use a buffer of M/40 borax/M/40 succinic acid, dissolve the enzyme preparation in each pH buffer to give a uricase activity of 0.2 U/ml, and incubate at 25°C for 20 hours. After keeping, add M/20 borax to 1 ml of these enzyme solutions.
Add 9ml of 10KH 2 PO 4 buffer (PH8.5) to adjust the pH.
was set at around 8.5. 0.5ml of these enzyme samples
Measure the enzyme activity by the method described above using
The results expressed in terms of relative activity are shown in Figure 2. This enzyme was stable in the pH range of 7.0 to 9.8. (3) Optimal temperature Dissolve the enzyme preparation in M/20 borax/M/10KH 2 PO 4 (PH8.5) to a concentration of 0.02U/ml. Set the reaction temperature to 20, 25, 30, 35, 37, 40, 45, 50,
55, 60, 65, 70℃. The optimal reaction temperature was determined by changing only the reaction temperature using the method for measuring uricase activity described above. The results are shown in Figure 3, and it was found that the optimum temperature was in the range of 37°C to 40°C. (4) Stable temperature range Dissolve the enzyme preparation in M/20 borax/M/10KH 2 PO 4 buffer (PH8.5) to a concentration of 0.02U/ml, and heat it to each temperature shown in Figure 4 for 10 minutes. After holding, enzyme activity was measured using 0.5 ml of each sample according to the method described above. Highly active value
Figure 4 shows the relative activity at each temperature when it is set to 100. This enzyme showed no inactivation even after treatment for 30 minutes at temperatures up to 55℃, and at 65℃ and 10 minutes.
Approximately 40% activity remained even after treatment for several minutes. (5) Substrate specificity Dissolve the enzyme preparation in M/20 borax/M/10KH 2 PO 4 buffer (PH8.5) to a concentration of 0.02U/ml. The amount of substrate reduction is measured in the same manner as the method for measuring uricase activity described above, except that the substrate shown in Table 1 is used. The maximum absorption wavelength of each substrate is used as the measurement wavelength for absorbance.
Table 1 shows the relative activity for each substrate, taking the activity when using uric acid as a substrate as 100.
【表】
第1表から本ウリカーゼは尿酸に基質特異性
を有することが判る。
(6) ミカエリス定数
酵素標品を0.02U/mlになるようにM/20ホ
ウ砂・M/10KH2PO4バツフアー(PH8.5)に溶
解する。種々の濃度の基質溶液を調製する。基
質濃度以外は前記ウリカーゼ活性の測定法と同
様に測定する。初発基質濃度〔S〕と得られた
酵素活性性値(U)をLineweaver−Burkの方
法にしたがつて逆数プロツトした結果、ミカエ
リス定数Km(尿酸)は9.52×10-6Mとなつ
た。
(7) 等電点
エレクトロフオーカシング法によつて等電点
を調べた。11.04U(蛋白質0.96mg)の試料を使
用した。110mlのカラムを用いて、PH3.5〜10.0
の範囲のAmpholine(キヤリヤー・アンフオラ
イトLKB社製)、シヨ糖蜜度勾配で2℃、
900V、40時間泳動した。分取は1分画あたり
2g、120ml/hrで行なつた。分画物のPH勾配
と活性の関係を調べた結果、本酵素の等電点
(Ip)は9.45であることが判つた。
以下、本発明の実施例を示す。
実施例 1
ウリカーゼ生産菌としてトルロプシス・ウリコ
キシダンスTN1023(微工研菌寄第5391号)を使
用する。
グルコース2g/dl、塩化ナトリウム0.05g/
dl、KH2PO40.1g/dl、MgSO4・7H2O0.05g/
dl、(NH4)2SO40.6g/dl、コーンンスチープ・
リカー2g/dlよりなる培地(PH5.5)30mlを300
ml容三角フラスコに入れ、120℃で15分間殺菌す
る。別に、尿素6gを水に溶解後、水で100mlに
なるように調製し、この調製液を120℃で3分間
殺菌後、その1mlを上の殺菌後の培地30mlに添加
する。この培地における尿素の割合は、0.2g/
dlである。培地調製後、前記菌を接種する。接種
はあらかじめ2日間培養した寒天培地より1白金
耳をとり上記培地に移して行なつた。培養は240
回転/分のロータリー・シエーカーで30℃、24時
間行なう。
次に、グルコース90g、コーン・スチープ・リ
カー60g、KCl1.5g、Na2HPO4・12H2O6g、
KH2PO43g、MgSO4・7H2O1.5g、
(NH4)2SO418g、尿素1.5gを3.0になるように
溶解した本培地(PH5.5)を、5容ジヤー・フ
アーメンターに入れる。これを120℃で30分間殺
菌、冷却後、該ジヤー・フアーメンターに上記の
フラスコ液を植菌する。本培養は通気量3/
分、撹拌500回転/分、温度30℃で30時間行な
う。培養後遠心分離して菌体220g(湿重量)を
得る。この菌体にM/40ホウ砂・M/20KH2PO4
バツフアー(PH8.5)5を加えて洗浄し、遠心
分離によつて菌体を得る。この菌体を上記バツフ
アー1に懸濁したのち、ダイノ・ラボラトリ
ー・ミル(Dyno Laboratory Mill)KDL型
(Willy A.、Bachofen Inc.、Switzerlandにより
製造されている)にて菌体を砕砕し、菌体破砕液
を得る。菌体破砕液を遠心分離して上清液を得
る。この上清液のウリカーゼ活性を測定した結
果、この上清液1.2中には約98.65Uのウリカー
ゼが含まれていた。この上清液に硫安を添加して
硫安30%飽和とし、沈殿物を遠心分離により除
き、上清液を得る。さらに硫安を添加して硫安60
%飽和とし、沈殿物を遠心分離により集める。こ
の沈殿物をM/40ホウ砂・M/20KH2PO4バツフ
アー(PH8.5)180mlにとかし、同バツフアー20
を用い、セロフアンチユーブを透析膜として、5
℃で一夜透析を行なう。透析チユーブ内液をM/
40ホウ砂・M/20KH2PO4バツフアー(PH8.5)で
平衡化したDEAE−セルロース1を充填したカ
ラムにチヤージし、M/40ホウ砂・M/
20KH2PO4バツフアー(PH8.5)1で洗浄する。
この操作によつてサンプル中のほとんどの蛋白質
はDEAE−セルロースに吸着されるが、本ウリカ
ーゼは吸着されないで大部分のウリカーゼは洗浄
液中に回収される。本洗浄液を20gずつ分画し、
ウリカーゼ溶出区分を集め、硫安60%飽和とし、
沈殿物を遠心分離により集める。この沈殿物を
M/40ホウ砂・M/20KH2POバツフアー(PH
8.5)60mlに溶解し、同じバツフアー(PH8.5)10
を用いて、セロフアンチユーブを透析膜とし
て、5℃で一夜透析を行なう。この透析内液を
M/40ホウ砂・M/20KH2PO4バツフアー(PH
8.5)で平衡化したDEAE−セルロース500mlを充
填したカラムにチヤージし、同バツフアー500ml
で洗浄してウリカーゼを溶出する。溶出液を20g
ずつ分画し、ウリカーゼ画分を集める。これに硫
安を添加して60%飽和とし、生成する沈殿物を遠
心分離により得る。この沈殿物をM/40ホウ砂・
M/20KH2PO4バツフアー(PH8.5)20mlに溶解
し、セフアデツクスG−200 600mlを充填したカ
ラムにチヤージし、同バツアーで溶出する。溶出
液を20gづつ分画し、ウリカーゼ活性画分を集め
(240ml)、限外過器(バイオエンジニアリング
株式会社、MC−2A型)で限外過膜ダイアフイ
ルターF−50T(バイオエンジニアリング株式
会社)で20mlまで濃縮してウリカーゼ4mgを得
た。菌体破砕液を遠心分離して得られた上清液か
らの活性収率は26.9%で、比活性は6.6U/mg蛋白
質である。
実施例 2
クエン酸4g/dl、コーンスチーブリカー0.5
g/dl、肉エキス(極東エールリツヒ)0.5g/
dl、KH2PO40.1g/dl、MgSO4・7H2O0.05g/
dl、FeSO4・7H2O1mg/、CoSO4・7H2O1mg/
dl、NaCl0.1g/dl、(NH4)2SO40.6g/dlよりな
る培地(PHはNaOHで3.50とする)300mlを2
容三角フラスコに入れ、120℃で15分間殺菌す
る。殺菌後、トルロプシス・ウリコキシダンス
TN1023(微工研菌寄第55391号)を接種する。接
種はあらかじめ2日間培養して寒天培地に生育し
た菌体を殺菌水に懸濁したのち上記培地に接種し
て行なつた。培養は240回転/分のロータリー・
シエーカーで30℃、24時間行なう。この培養液を
下記のように調整した30容ジヤー・フアーメン
ターに移した。本培地はクエン酸1.2Kg、コーン
スチープリカー100g、肉エキス(極東エールリ
ツヒ)100g、KH2PO420g、MgSO4・7H2O10
g、FeSO4・7H2O20mg、MnSO4・7H2O20mg、
CoCl2・6H2O20mg、NaCl20g、尿酸40gを15
となるように溶解した。該培地のPHをNaOHで
3.50になるように調整したのち、30容ジヤーフ
アーメンタに移し、120℃で、5分間、蒸気を吹
き込んで殺菌する。30℃まで冷却したのち、殺菌
水を加えて培地の液量を20とし、上記のシード
を植菌する。培養は通気量10/分、撹拌300回
転/分、温度30℃で28時間行なう。培養終了後、
培養液を遠心分離して菌体1465g(湿重量)を得
る。この菌体にM/40ホウ砂・M/20KH2PO4バ
ツフアー(PH8.5)10を加えて洗浄し、遠心分
離によつて菌体を得る。この菌体を同じバツフア
ー(PH8.5)6に懸濁したのち、ダイノラボラ
トリー・ミル(DynoLaboratory Mill)KDL型
(Willy A、Bachofen Inc.、Switzerland)によ
り製造されている)にて菌体破砕液を遠心分離し
て上清液を得る。この上清液のウリカーゼ活性を
測定したところ、この上清液中には1460Uのウリ
カーゼが含まれていた。この上清液に硫安を添加
して30%飽和とし、沈殿物を遠心分離により除
き、上清液を得る。さらに硫安を添加して硫安60
%飽和とし、沈殿物を遠心分離により集める。こ
の沈殿物をM/40ホウ砂・M/20KH2PO4バツフ
アー(PH8.5)360mlにとかし、セロハンチユーブ
を透析膜として用い、同じバツフアー30中で一
夜5℃で透析する。透析チユーブ内液をM/40ホ
ウ砂・M/20KH2PO4バツフアー(PH8.5)で平衡
化したDEAE−セルロース2を充填したカラム
にチヤージし、同じバツフアー2で洗浄する。
この操作でサンプル中の大部分の蛋白質はDEAE
セルロースに吸着されるが、本ウリカーゼは吸着
されないで洗浄液中に回収される。本洗浄液は20
gずつ分画し、ウリカーゼ溶出区分を集め、硫安
60%飽和とし遠心分離によつて沈殿物を集める。
この沈殿物を上記バツフアー120mlに溶解し、同
じバツフアー10中でセロフアンチユーブを用い
て透析を行なう。透析は5℃で一夜行なつた後、
透析内液をM/40ホウ砂・M/20KH2PO4バツフ
アー(PH8.5)で平衡化したDEAE−セルロース
1を充填したカラムにチヤージし、同じバツフ
アー1で洗浄してウリカーゼを溶出する。溶出
液を20gずつ分画し、ウリカーゼ画分を集める。
これに硫安を添加して60%飽和とし、生成する沈
殿を遠心分離により得る。この沈殿物をM/40ホ
ウ砂・M/20KH2PO4バツフアー(PH8.5)40mlに
溶解し、セフアデツクスG150 1.2を充填した
カラムにチヤージし、同じバツフアーで溶出す
る。溶出液を20gずつ分画し、ウリカーゼ画分を
集め(420ml)、限外過器MC−2A型およびMC
−4A型(バイオエンジニアリング社)で限外
過膜ダイーフイルターF−50T(バイオエンジ
ニアリング社)で28mlまで濃縮した。この酵素液
をM/50K2HPO4・M/50KH2PO4(PH8.0)で平
衡化したハイドロキシアパタイト220mlを充填し
たカラムにチヤージし、同バツフアー450mlを使
用して洗浄したのち、M/5K2HPO4・M/
5KH2PO4バツフアー(PH8.0)で溶出する。溶出
液を20gずつ分画し、ウリカーゼ画分(200ml)
を集め、上の限外過器を使用して16mlまで濃縮
してウリカーゼ15.4mgを得た。菌体破砕液を遠心
分離して得られた上清液からの活性収率は12.1%
で、比活性は11.5U/mg蛋白質である。
実施例 3
尿酸(第2表に示す濃度)、グルコース3.0g/
dl、コーン・スチーブ・リカー1.0g/dl、
KCl0.05g/dl、KH2PO40.1g/dl、Na2HPO4・
12H2O0.2g/dl、(NH4)2SO40.6g/dl、肉エキ
ス1.0g/dl、酵母エキス0.1g/dl、尿素※0.2
g/dlよりなる培地(PH5.5)50mlを500ml容振盪
フラスコに入れ、120℃で15分間殺菌する。〔※こ
の際尿素は10g/100mlの溶液を調製し、120℃で
3分間殺菌後、各1mlを殺菌後の培地(50ml)に
添加する〕。各培地にトルロプシス・ウリコキシ
ダンスTN1023(微工研菌寄第5391号)を1白金
耳接種し、28℃で48時間振盪培養する。培養終了
後、培養物を遠心分離して(8000rpm15分)菌体
を得る。培養液と同量のM/40ホウ砂・M/
20KH2PO4バツフアー(PH8.5)を使用して洗浄
し、再び遠心分離によつて菌体を得る。得られた
湿菌体1gとガラスビーズ(0.25〜0.50mmφ)10
gを上記のホウ酸バツフアー5mlに懸濁し、耐圧
ガラス製試験管を用い周囲を氷水で冷却しなが
ら、内部を高速の撹拌羽根によつて撹拌すること
によつて摩砕した。摩砕液を遠心分離
(10000rpm10分)して上清液を得る。該上清液中
のウリカーゼ活性を測定して、第2表の結果を得
る。[Table] Table 1 shows that this uricase has substrate specificity for uric acid. (6) Michaelis constant Dissolve the enzyme preparation in M/20 borax/M/10KH 2 PO 4 buffer (PH 8.5) to a concentration of 0.02 U/ml. Prepare substrate solutions of various concentrations. The measurement is performed in the same manner as the method for measuring uricase activity described above except for the substrate concentration. As a result of reciprocal plotting of the initial substrate concentration [S] and the obtained enzyme activity value (U) according to the Lineweaver-Burk method, the Michaelis constant Km (uric acid) was 9.52×10 −6 M. (7) Isoelectric point The isoelectric point was investigated using the electrofocusing method. A sample of 11.04U (0.96mg protein) was used. PH3.5~10.0 using 110ml column
Ampholine (manufactured by Carrier Ampholite LKB) in the range of 2°C on a molasses gradient,
Electrophoresis was performed at 900V for 40 hours. The fractionation was carried out at 2 g per fraction at a rate of 120 ml/hr. As a result of examining the relationship between the PH gradient and activity of the fraction, it was found that the isoelectric point (Ip) of this enzyme was 9.45. Examples of the present invention will be shown below. Example 1 Torulopsis uricoxidans TN1023 (Feikoken Bibori No. 5391) is used as a uricase-producing bacterium. Glucose 2g/dl, Sodium chloride 0.05g/
dl, KH 2 PO 4 0.1g/dl, MgSO 4・7H 2 O 0.05g/
dl, (NH 4 ) 2 SO 4 0.6g/dl, Corn Steep・
30ml of medium (PH5.5) consisting of 2g/dl of liquor
Pour into a ml Erlenmeyer flask and sterilize at 120℃ for 15 minutes. Separately, dissolve 6 g of urea in water, prepare the volume with water to 100 ml, sterilize this prepared solution at 120°C for 3 minutes, and then add 1 ml of the solution to 30 ml of the above sterilized medium. The proportion of urea in this medium is 0.2g/
It is dl. After preparing the medium, the bacteria are inoculated. Inoculation was carried out by taking one platinum loopful from an agar medium cultured for two days in advance and transferring it to the above medium. Culture is 240
Carry out 24 hours at 30°C in a rotary shearer at revolutions per minute. Next, 90 g of glucose, 60 g of corn steep liquor, 1.5 g of KCl, 6 g of Na 2 HPO 4 12H 2 O,
KH 2 PO 4 3g, MgSO 4・7H 2 O 1.5g,
This medium (PH 5.5) containing 18 g of (NH 4 ) 2 SO 4 and 1.5 g of urea dissolved to a pH of 3.0 is placed in a 5-volume jar fermenter. After sterilizing this at 120° C. for 30 minutes and cooling, the jar fermenter is inoculated with the above flask solution. Main culture is aeration amount 3/
minutes, stirring at 500 revolutions/minute and temperature at 30°C for 30 hours. After culturing, centrifuge to obtain 220 g (wet weight) of bacterial cells. Add M/40 borax, M/20KH 2 PO 4 to this bacterial body.
Wash by adding buffer (PH8.5) 5, and obtain bacterial cells by centrifugation. After suspending the bacterial cells in the above-mentioned buffer 1, the bacterial cells were crushed in a Dyno Laboratory Mill KDL type (manufactured by Willy A., Bachofen Inc., Switzerland). Obtain a cell suspension. Centrifuge the cell suspension to obtain a supernatant. As a result of measuring the uricase activity of this supernatant, it was found that this supernatant 1.2 contained about 98.65 U of uricase. Ammonium sulfate is added to this supernatant to make it 30% saturated with ammonium sulfate, and the precipitate is removed by centrifugation to obtain a supernatant. Add ammonium sulfate to 60% ammonium sulfate.
% saturation and collect the precipitate by centrifugation. Dissolve this precipitate in 180ml of M/40 borax/M/20KH 2 PO 4 buffer (PH8.5) and add 20
using cellophane tube as a dialysis membrane, 5
Perform dialysis overnight at °C. M/ the fluid inside the dialysis tube.
Charge a column packed with DEAE-Cellulose 1 equilibrated with 40KH 2 PO 4 buffer (PH8.5) and add M/40 Borax/M/
Wash with 20KH 2 PO 4 buffer (PH8.5) 1.
By this operation, most of the proteins in the sample are adsorbed to DEAE-cellulose, but the present uricase is not adsorbed and most of the uricase is recovered in the washing solution. This washing solution was fractionated into 20g portions,
Collect the uricase elution fraction and make it 60% saturated with ammonium sulfate.
Collect the precipitate by centrifugation. This precipitate is mixed with M/40 borax, M/20KH 2PO borax (PH
8.5) Dissolve in 60ml of the same buffer (PH8.5) 10
Dialysis is performed overnight at 5°C using cellophane tube as a dialysis membrane. This dialysis fluid was mixed with M/40 borax, M/20KH 2 PO 4 buffer (PH
Charge the column packed with 500 ml of DEAE-cellulose equilibrated with 8.5), and add 500 ml of the same buffer.
Wash with water to elute uricase. 20g of eluate
Collect the uricase fraction. Ammonium sulfate is added to this to make it 60% saturated, and the resulting precipitate is obtained by centrifugation. This precipitate was mixed with M/40 borax.
Dissolve in 20 ml of M/20KH 2 PO 4 buffer (PH8.5), charge to a column packed with 600 ml of Sephadex G-200, and elute with the same buffer. Fractionate the eluate into 20 g portions, collect the uricase active fractions (240 ml), and filter them using an ultrafilter (Bio Engineering Co., Ltd., MC-2A model) using an ultrafiltration membrane diafilter F-50T (Bio Engineering Co., Ltd.). The mixture was concentrated to 20 ml to obtain 4 mg of uricase. The activity yield from the supernatant obtained by centrifuging the cell suspension was 26.9%, and the specific activity was 6.6 U/mg protein. Example 2 Citric acid 4g/dl, corn steep liquor 0.5
g/dl, meat extract (Kyokuto Ehrlitsu) 0.5g/
dl, KH 2 PO 4 0.1g/dl, MgSO 4・7H 2 O 0.05g/
dl, FeSO 4・7H 2 O1mg/, CoSO 4・7H 2 O1mg/
dl, NaCl 0.1g/dl, (NH 4 ) 2 SO 4 0.6g/dl (PH is 3.50 with NaOH) 300ml
Place in an Erlenmeyer flask and sterilize at 120℃ for 15 minutes. Torulopsis uricoxidans after sterilization
Inoculate with TN1023 (Feikoken Bacteria No. 55391). Inoculation was carried out by inoculating the cells, which had been cultured for two days in advance and grown on an agar medium, into the above medium after suspending them in sterilized water. Cultivation is carried out using a rotary machine running at 240 revolutions/minute.
Perform in a sheaker at 30℃ for 24 hours. This culture solution was transferred to a 30-volume jar fermenter prepared as follows. This medium contains 1.2 kg of citric acid, 100 g of corn steep liquor, 100 g of meat extract (Kyokuto Ehrlich), 20 g of KH 2 PO 4 , MgSO 4.7H 2 O10
g, FeSO4・7H2O20mg , MnSO4・7H2O20mg ,
CoCl2・6H2O20mg , NaCl20g, uric acid 40g at 15
It was dissolved so that Adjust the pH of the medium with NaOH.
After adjusting the temperature to 3.50, transfer to a 30-volume jar fermentor and sterilize by blowing steam at 120℃ for 5 minutes. After cooling to 30°C, add sterilized water to make the volume of the medium 20°C, and inoculate the above seeds. Cultivation is carried out for 28 hours at an aeration rate of 10/min, stirring at 300 rpm, and a temperature of 30°C. After culturing,
The culture solution was centrifuged to obtain 1465 g (wet weight) of bacterial cells. The cells are washed by adding 10 times of M/40 borax/M/20KH 2 PO 4 buffer (PH8.5), and centrifuged to obtain cells. After suspending the cells in the same buffer (PH8.5) 6, the cell suspension was prepared using a DynoLaboratory Mill KDL type (manufactured by Willy A, Bachofen Inc., Switzerland). Centrifuge to obtain the supernatant. When the uricase activity of this supernatant was measured, it was found that this supernatant contained 1460 U of uricase. Ammonium sulfate is added to this supernatant to make it 30% saturated, and the precipitate is removed by centrifugation to obtain a supernatant. Add ammonium sulfate to 60% ammonium sulfate.
% saturation and collect the precipitate by centrifugation. This precipitate is dissolved in 360 ml of M/40 borax/M/20 KH 2 PO 4 buffer (PH 8.5) and dialyzed overnight at 5° C. in the same buffer 30 using a cellophane tube as a dialysis membrane. The solution inside the dialysis tube is charged to a column packed with DEAE-cellulose 2 equilibrated with M/40 borax/M/20KH 2 PO 4 buffer (PH8.5), and washed with the same buffer 2.
With this procedure, most of the proteins in the sample are DEAE
Although it is adsorbed to cellulose, this uricase is not adsorbed and is recovered in the washing solution. This cleaning solution is 20
Fractionate into g units, collect the uricase elution fraction, and add ammonium sulfate.
Bring to 60% saturation and collect the precipitate by centrifugation.
This precipitate is dissolved in 120 ml of the above buffer, and dialyzed using cellophane tube in the same buffer 10. After dialysis was performed overnight at 5°C,
The dialyzed solution is charged to a column packed with DEAE-cellulose 1 equilibrated with M/40 borax/M/20 KH 2 PO 4 buffer (PH8.5), and washed with the same buffer 1 to elute uricase. Fractionate the eluate into 20 g portions and collect the uricase fraction.
Add ammonium sulfate to achieve 60% saturation, and obtain the resulting precipitate by centrifugation. This precipitate is dissolved in 40 ml of M/40 borax/M/20 KH 2 PO 4 buffer (PH 8.5), charged to a column packed with Sephadex G150 1.2, and eluted with the same buffer. The eluate was fractionated into 20 g portions, the uricase fraction was collected (420 ml), and the uricase fraction was collected using an ultrafilter MC-2A type and MC.
-4A type (Bio Engineering Co., Ltd.) and concentrated to 28 ml using an ultrafiltration membrane die filter F-50T (Bio Engineering Co., Ltd.). This enzyme solution was charged to a column packed with 220 ml of hydroxyapatite equilibrated with M/50K 2 HPO 4 (PH8.0), washed with 450 ml of the same buffer, and then washed with M/50K 2 HPO 4 . 5K 2 HPO 4・M/
Elute at 5KH 2 PO 4 buffer (PH8.0). Fractionate the eluate into 20g portions and separate the uricase fraction (200ml).
was collected and concentrated to 16 ml using the ultrafilter above to obtain 15.4 mg of uricase. The activity yield from the supernatant obtained by centrifuging the cell suspension was 12.1%.
The specific activity is 11.5U/mg protein. Example 3 Uric acid (concentration shown in Table 2), glucose 3.0g/
dl, corn stave liquor 1.0g/dl,
KCl0.05g/dl, KH 2 PO 4 0.1g/dl, Na 2 HPO 4・
12H 2 O 0.2g/dl, (NH 4 ) 2 SO 4 0.6g/dl, meat extract 1.0g/dl, yeast extract 0.1g/dl, urea*0.2
Pour 50 ml of a medium (PH 5.5) consisting of g/dl into a 500 ml shake flask and sterilize at 120°C for 15 minutes. [*At this time, prepare a solution of 10 g/100 ml of urea, sterilize it at 120°C for 3 minutes, and then add 1 ml of each to the sterilized medium (50 ml)]. One platinum loop of Torulopsis uricoxidans TN1023 (Feikoken Bacteria No. 5391) was inoculated into each medium and cultured with shaking at 28°C for 48 hours. After the cultivation is completed, the culture is centrifuged (8000 rpm for 15 minutes) to obtain bacterial cells. Same amount of M/40 borax as the culture solution
Wash using 20KH 2 PO 4 buffer (PH8.5) and centrifuge again to obtain bacterial cells. 1g of the obtained wet bacterial cells and 10 glass beads (0.25-0.50mmφ)
g was suspended in 5 ml of the above boric acid buffer, and ground using a pressure-resistant glass test tube while cooling the surrounding area with ice water and stirring the inside with a high-speed stirring blade. Centrifuge the triturate (10,000 rpm for 10 minutes) to obtain a supernatant. The uricase activity in the supernatant is measured to obtain the results shown in Table 2.
【表】
第2表から判る様に、培地中に尿酸を添加する
こと、特に0.05g/dl以上添加することによりウ
リカーゼが上清液中に著量に生成している。[Table] As can be seen from Table 2, by adding uric acid to the medium, especially by adding 0.05 g/dl or more, uricase was produced in a significant amount in the supernatant.
第1図は本ウリカーゼの相対活性と至適PHとの
関係を示す。第2図は本ウリカーゼの相対活性と
安定PH範囲との関係を示す。
但し●−●:M/40ホウ砂・M/20KH2PO4バ
ツフアー、Γ−Γ:M/40ホウ砂・M/40コハク
酸バツフアー。
第3図は本ウリカーゼの相対活性と至適温度と
の関係を示す。第4図は本ウリカーゼの相対活性
と処理温度との関係を示す。
FIG. 1 shows the relationship between the relative activity of the present uricase and the optimum pH. Figure 2 shows the relationship between the relative activity of the present uricase and the stable PH range. However, ●-●: M/40 borax, M/20KH 2 PO 4 buffer, Γ-Γ: M/40 borax, M/40 succinic acid buffer. FIG. 3 shows the relationship between the relative activity of the present uricase and the optimum temperature. FIG. 4 shows the relationship between the relative activity of the present uricase and the treatment temperature.
Claims (1)
有する微生物を栄養培地に培養し、培養物中にウ
リカーゼを生成せしめ、これを採取することを特
徴とするウリカーゼの製造法。1. A method for producing uricase, which comprises culturing a microorganism belonging to the genus Torulopsis and having uricase-producing ability in a nutrient medium, producing uricase in the culture, and collecting the same.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2611780A JPS56124381A (en) | 1980-03-04 | 1980-03-04 | Preparation of uricase by fermentation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2611780A JPS56124381A (en) | 1980-03-04 | 1980-03-04 | Preparation of uricase by fermentation method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56124381A JPS56124381A (en) | 1981-09-30 |
JPS6243669B2 true JPS6243669B2 (en) | 1987-09-16 |
Family
ID=12184627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2611780A Granted JPS56124381A (en) | 1980-03-04 | 1980-03-04 | Preparation of uricase by fermentation method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56124381A (en) |
-
1980
- 1980-03-04 JP JP2611780A patent/JPS56124381A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS56124381A (en) | 1981-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1156573A (en) | Strain uk 788 and process for producing a useful enzyme | |
US4987076A (en) | Uricase and a method for the preparation thereof | |
KR880001944B1 (en) | 2,5-diketo-d-gluconic acid reductase | |
DE3320495A1 (en) | MICROBIOLOGICALLY PRODUCED D-2-HYDROXY-4-METHYLPENTANIC ACID DEHYDROGENASE, METHOD FOR THEIR DETERMINATION AND THEIR USE | |
US4062731A (en) | Production of uricase from micrococcus luteus | |
EP0029976B1 (en) | A biologically pure culture of strain ifo 14093 and a process for producing an intracellular component herefrom | |
JPS61187787A (en) | Polypeptide product | |
CA1318631C (en) | Process for production of superoxide dismutase | |
JPS6243669B2 (en) | ||
JPS61115489A (en) | Preparation of bacteriolytic enzyme | |
DE3041744C2 (en) | ||
US5610045A (en) | Producing a high content of acetate kinase using bacillus stearothermophilus | |
JP2961178B2 (en) | Method for producing β-1,4-mannanase by microorganism | |
Fensom et al. | The use of ferricyanide for the production of 3‐keto sugars by non‐growing suspensions of Agrobacterium tumefaciens | |
JPS6243671B2 (en) | ||
JP3152855B2 (en) | Novel sorbitol dehydrogenase, method for producing the same, reagent and method for quantifying sorbitol using the enzyme | |
JPS6143987A (en) | Peroxidase and its preparation | |
JPH0260313B2 (en) | ||
JPS6228678B2 (en) | ||
JPS5840466B2 (en) | Production method of acyl-CoA oxidase | |
KR960007741B1 (en) | Novel(alpha)-1,6-glucosidase and process for producing the same | |
JP3629290B2 (en) | Manufacturing method of substance | |
JPS6098982A (en) | Preparation of enzyme for measuring polyamine | |
JP3125955B2 (en) | Thermostable phosphoenolpyruvate carboxylase and method for producing the same | |
JPS58165789A (en) | Preparation of alpha-glycerophosphate oxidase |